Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy

NCT02851797 is registered in ClinicalTrials.gov with Italfarmaco as lead sponsor.

NCT NCT02851797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02851797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Double Blind, Placebo Controlled, Multicentre Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy
Lead sponsor
Italfarmaco
Phase
Phase 3
Overall status
Completed
Start date
June 6, 2017
Completion date
February 22, 2022
Enrollment
179 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy